GEORGE ANDERSON: Open Payments
NPI 1801320130 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 17 payments from 11 companies in 2025. Trend: 2023 $589 · 2024 $772 · 2025 $645
Food & beverage: $546Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $127 |
| Biofrontera Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| ABBVIE INC. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| LEO Pharma Inc. | 1 | $29 |
| Coastal Medical Technologies LLC | 1 | $28 |
| Amgen Inc. | 1 | $20 |
Products named: TREMFYA, DUPIXENT, SPEVIGO, COSENTYX, SKYRIZI, ILUMYA, ANZUPGO, OTEZLA.
Industry payments across FL — which companies pay providers there.
